Skip to main content
Top

Drugs

Issue 11/2020

Content (12 Articles)

New and Emerging Systemic Treatments for Atopic Dermatitis

Megan Newsom, Arjun M. Bashyam, Esther A. Balogh, Steven R. Feldman, Lindsay C. Strowd

Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation

Irene Motta, Rayan Bou-Fakhredin, Ali T. Taher, Maria Domenica Cappellini

Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice

Alberto Corsini, Nicola Ferri, Marco Proietti, Giuseppe Boriani

Selpercatinib: First Approval

  • Open Access
  • NSCLC
  • AdisInsight Report

Anthony Markham

Capmatinib: First Approval

  • NSCLC
  • AdisInsight Report

Sohita Dhillon

Ripretinib: First Approval

Sohita Dhillon

Comment on: “Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs”

M. Eerdekens, M. Stupar, L. Marcondes

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images